CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice

Tackling Pharma’s Shadow Market: Getting ‘Smarter’ in the Fight Against Fake Pharmaceuticals

If you were to ask a member of the public “what is the world’s most counterfeited product?”, it’s highly likely they’ll say designer handbags or watches. But, in fact, the world’s largest fraud market is pharmaceuticals – and by a large margin. The larger the industry supplying a consumer product, the more likely it is that criminals will try and exploit it. And with counterfeit and falsified medicine, the profits can be huge. But so too can the risks to public health and the industry’s reputation. Rich Quelch at Origin explains why this risk is growing, accelerated by the disruption of the COVID-19 pandemic, complex global supply chains, widening access to healthcare in emerging economies and the rise of pharmaceutical e-commerce.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026